Viridian Therapeutics, Inc.\DE (VRDN) Leases (2016 - 2025)
Historic Leases for Viridian Therapeutics, Inc.\DE (VRDN) over the last 9 years, with Q3 2025 value amounting to $2.6 million.
- Viridian Therapeutics, Inc.\DE's Leases rose 41640.0% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 41640.0%. This contributed to the annual value of $2.2 million for FY2024, which is 3203.59% up from last year.
- Latest data reveals that Viridian Therapeutics, Inc.\DE reported Leases of $2.6 million as of Q3 2025, which was up 41640.0% from $2.0 million recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Leases registered a high of $2.6 million during Q3 2025, and its lowest value of $500000.0 during Q3 2024.
- In the last 5 years, Viridian Therapeutics, Inc.\DE's Leases had a median value of $1.6 million in 2022 and averaged $1.7 million.
- Its Leases has fluctuated over the past 5 years, first skyrocketed by 50150.38% in 2021, then tumbled by 7304.58% in 2024.
- Over the past 5 years, Viridian Therapeutics, Inc.\DE's Leases (Quarter) stood at $1.7 million in 2021, then fell by 4.17% to $1.6 million in 2022, then rose by 3.73% to $1.7 million in 2023, then surged by 32.04% to $2.2 million in 2024, then grew by 17.1% to $2.6 million in 2025.
- Its Leases stands at $2.6 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.1 million for Q1 2025.